News

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.
Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.
Prostate cancer is the second most common cancer in men, often going undetected until later stages due to silent symptoms and ...
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced ...
Get prostate cancer treatment latest news, Article video and Photos on prostate cancer treatment Explore latest health updates, news, information from TheHealthSite.com ...
MSD and Daiichi Sankyo have announced first subject dosing in the IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan ...
Acupuncture produced significantly greater reductions in nocturia episodes and IPSS scores in survivors of prostate cancer ...
A review of 22 trials led the American Society of Clinical Oncology (ASCO) to issue updates to its mCRPC systemic therapy ...